Heron Therapeutics | HRTX - Ebit

Prezzo Delle Azioni
1.07
Cambio Giornaliero
-0.06 -5.31%
Mensile
-15.08%
Annuale
-54.66%
Q1 Previsione
1.15




Ebit Cambiamento Data
ALKERMES USD -10.95M 100.03M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -1.7M 8.47M 2025-09
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Anika Therapeutics USD -4.28M 3.58M 2025-03
Arrowhead Research USD 40.81M 17.01M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Esperion Therapeutics USD -16.03M 11.51M 2024-09
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Heron Therapeutics USD -4.46M 5.76M 2024-09
Insmed USD -249.71M 11.64M 2025-12
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
Merck USD 6.24B 1.32B 2025-12
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 3.19M 9.96M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Surmodics USD -322K 2.13M 2023-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Veracyte USD 24.63M 1.52M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12